173 related articles for article (PubMed ID: 21478494)
1. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.
Nan H; Xu M; Zhang J; Zhang M; Kraft P; Qureshi AA; Chen C; Guo Q; Hu FB; Rimm EB; Curhan G; Song Y; Amos CI; Wang LE; Lee JE; Wei Q; Hunter DJ; Han J
Hum Mol Genet; 2011 Jul; 20(13):2673-9. PubMed ID: 21478494
[TBL] [Abstract][Full Text] [Related]
2. Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma.
Ransohoff KJ; Wu W; Cho HG; Chahal HC; Lin Y; Dai HJ; Amos CI; Lee JE; Tang JY; Hinds DA; Han J; Wei Q; Sarin KY
Oncotarget; 2017 Mar; 8(11):17586-17592. PubMed ID: 28212542
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
[TBL] [Abstract][Full Text] [Related]
4. Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.
Roos L; Sandling JK; Bell CG; Glass D; Mangino M; Spector TD; Deloukas P; Bataille V; Bell JT
J Invest Dermatol; 2017 Apr; 137(4):910-920. PubMed ID: 27993549
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.
Landi MT; Bishop DT; MacGregor S; Machiela MJ; Stratigos AJ; Ghiorzo P; Brossard M; Calista D; Choi J; Fargnoli MC; Zhang T; Rodolfo M; Trower AJ; Menin C; Martinez J; Hadjisavvas A; Song L; Stefanaki I; Scolyer R; Yang R; Goldstein AM; Potrony M; Kypreou KP; Pastorino L; Queirolo P; Pellegrini C; Cattaneo L; Zawistowski M; Gimenez-Xavier P; Rodriguez A; Elefanti L; Manoukian S; Rivoltini L; Smith BH; Loizidou MA; Del Regno L; Massi D; Mandala M; Khosrotehrani K; Akslen LA; Amos CI; Andresen PA; Avril MF; Azizi E; Soyer HP; Bataille V; Dalmasso B; Bowdler LM; Burdon KP; Chen WV; Codd V; Craig JE; Dębniak T; Falchi M; Fang S; Friedman E; Simi S; Galan P; Garcia-Casado Z; Gillanders EM; Gordon S; Green A; Gruis NA; Hansson J; Harland M; Harris J; Helsing P; Henders A; Hočevar M; Höiom V; Hunter D; Ingvar C; Kumar R; Lang J; Lathrop GM; Lee JE; Li X; Lubiński J; Mackie RM; Malt M; Malvehy J; McAloney K; Mohamdi H; Molven A; Moses EK; Neale RE; Novaković S; Nyholt DR; Olsson H; Orr N; Fritsche LG; Puig-Butille JA; Qureshi AA; Radford-Smith GL; Randerson-Moor J; Requena C; Rowe C; Samani NJ; Sanna M; Schadendorf D; Schulze HJ; Simms LA; Smithers M; Song F; Swerdlow AJ; van der Stoep N; Kukutsch NA; Visconti A; Wallace L; Ward SV; Wheeler L; Sturm RA; Hutchinson A; Jones K; Malasky M; Vogt A; Zhou W; Pooley KA; Elder DE; Han J; Hicks B; Hayward NK; Kanetsky PA; Brummett C; Montgomery GW; Olsen CM; Hayward C; Dunning AM; Martin NG; Evangelou E; Mann GJ; Long G; Pharoah PDP; Easton DF; Barrett JH; Cust AE; Abecasis G; Duffy DL; Whiteman DC; Gogas H; De Nicolo A; Tucker MA; Newton-Bishop JA; ; ; ; ; ; ; ; ; ; Peris K; Chanock SJ; Demenais F; Brown KM; Puig S; Nagore E; Shi J; Iles MM; Law MH
Nat Genet; 2020 May; 52(5):494-504. PubMed ID: 32341527
[TBL] [Abstract][Full Text] [Related]
6. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
Duffy DL; Zhu G; Li X; Sanna M; Iles MM; Jacobs LC; Evans DM; Yazar S; Beesley J; Law MH; Kraft P; Visconti A; Taylor JC; Liu F; Wright MJ; Henders AK; Bowdler L; Glass D; Ikram MA; Uitterlinden AG; Madden PA; Heath AC; Nelson EC; Green AC; Chanock S; Barrett JH; Brown MA; Hayward NK; MacGregor S; Sturm RA; Hewitt AW; ; Kayser M; Hunter DJ; Newton Bishop JA; Spector TD; Montgomery GW; Mackey DA; Smith GD; Nijsten TE; Bishop DT; Bataille V; Falchi M; Han J; Martin NG
Nat Commun; 2018 Nov; 9(1):4774. PubMed ID: 30429480
[TBL] [Abstract][Full Text] [Related]
7. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
[No Abstract] [Full Text] [Related]
8. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
[TBL] [Abstract][Full Text] [Related]
9. An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.
Bertram CG; Gaut RM; Barrett JH; Randerson-Moor J; Whitaker L; Turner F; Bataille V; dos Santos Silva I; Swerdlow AJ; Bishop DT; Newton Bishop JA
J Invest Dermatol; 2004 Feb; 122(2):429-32. PubMed ID: 15009726
[TBL] [Abstract][Full Text] [Related]
10. Variants at the 9p21 locus and melanoma risk.
Maccioni L; Rachakonda PS; Bermejo JL; Planelles D; Requena C; Hemminki K; Nagore E; Kumar R
BMC Cancer; 2013 Jul; 13():325. PubMed ID: 23816148
[TBL] [Abstract][Full Text] [Related]
11. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
12. Genes Determining Nevus Count and Dermoscopic Appearance in Australian Melanoma Cases and Controls.
Duffy DL; Jagirdar K; Lee KJ; McWhirter SR; McMeniman EK; De'Ambrosis B; Pflugfelder A; Rayner JE; Whiteman DC; Brown MA; Martin NG; Smithers BM; Schaider H; Soyer HP; Sturm RA
J Invest Dermatol; 2020 Feb; 140(2):498-501.e17. PubMed ID: 31421127
[No Abstract] [Full Text] [Related]
13. Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk.
Liu H; Wang LE; Liu Z; Chen WV; Amos CI; Lee JE; ; ; Iles MM; Law MH; Barrett JH; Montgomery GW; Taylor JC; MacGregor S; Cust AE; Newton Bishop JA; Hayward NK; Bishop DT; Mann GJ; Affleck P; Wei Q
Carcinogenesis; 2013 Apr; 34(4):885-92. PubMed ID: 23291271
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
15. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
[TBL] [Abstract][Full Text] [Related]
16. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
[TBL] [Abstract][Full Text] [Related]
17. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
18. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
[TBL] [Abstract][Full Text] [Related]
20. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
